Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1431 clinical trials
Sympathoinhibition as a Preferred Second Line Treatment of Obesity Related Hypertension

This study is designed to investigate whether sympathoinhibition with moxonidine could provide added metabolic benefit compared to the second line therapy in the current guidelines.

moxonidine
ace inhibitor
amlodipine 5 mg
body mass index
hypertension
  • 0 views
  • 16 Feb, 2024
  • 1 location
Efficacy and Safety of Lenvatinib as a Conversion Therapy for HCC

The aim of the single-arm, open-label, phase II clinical trial is to assess efficacy and safety of lenvatinib as a preoperative conversion therapy in patients with potentially resectable HCC. Investigator hypothesized that lenvatinib may be an effective conversion treatment for HCC, and preoperative treatment with lenvatinib can improve resectability in …

  • 0 views
  • 16 Feb, 2024
  • 4 locations
Study: Effects of a Collaborative Occupational Therapy Interactive Vaulting

Occupational therapy services will be integrated into an interactive vaulting program which is an equine assisted activity. Children with disabilities ages 5-17 will participate. The objectives of this study are to determine the influence of a collaborative occupational therapy interactive vaulting program on the executive function and social participation in …

developmental disabilities
  • 0 views
  • 05 Aug, 2020
Mobile App as a Guide to Exercises for Patients With Chronic Stroke

Introduction: Stroke continues to be one of the leading causes of disability in the Spanish adult population with the presentation of impairments such as alteration of mobility and a consequent reduction in quality of life. These sequelae, generally chronic, generates a significant expense and saturation of social and health services.

hemiplegia
hemiplegia or hemiparesis
stroke
hemiparesis
physical rehabilitation
  • 0 views
  • 16 Feb, 2024
  • 1 location
FT596 as a Monotherapy and in Combination With Anti-CD20 Monoclonal Antibodies

This is a Phase I dose-finding study of FT596 as monotherapy and in combination with Rituximab or Obinutuzumab in subjects with relapsed/refractory B-cell Lymphoma or Chronic Lymphocytic Leukemia.

immunochemotherapy
treatment regimen
cyclophosphamide
leukemia
monoclonal protein
  • 0 views
  • 16 Feb, 2024
  • 3 locations
Carfilzomib Daratumumab Lenalidomide and Dexamethasone as First Line Treatment in Multiple Myeloma

Carfilzomib in combination with lenalidomide, daratumumab and dexamethasone (KRDd) can induce profound clinical responses. The investigators want to observe the effectiveness of the quadruple therapy of carfilzomib, lenalidomide, daratumumab and dexamethasone on patients receiving 8 cycles of KRDd with autologous stem cell transplantation versus patients with 8 cycles of KRDd …

autologous hematopoietic stem cell transplant
anemia
cell transplantation
bone lesion
bone marrow procedure
  • 0 views
  • 16 Feb, 2024
  • 1 location
  • 0 views
  • 07 Oct, 2022
  • 4 locations
Ketorolac as an Adjuvant Agent for Postoperative Pain Control Following Arthroscopic Meniscus Surgery

However, pain management in the post-operative period is critical to the ability to perform this procedure as an outpatient surgery. Traditionally, oral narcotic agents have been the preferred analgesic postoperatively in orthopaedic surgery.

analgesia
narcotics
NSAID
drug abuse
opioid
  • 0 views
  • 16 Feb, 2024
  • 1 location
Efficacy of rTMS and tDCS as Adjunctive Rehabilitation for Cerebrovascular Disease-related Gait Dysfunction

This study was a prospective, randomized, single-blind, parallel-controlled, multicenter clinical study to evaluate the efficacy and safety of repetitive transcranial magnetic stimulation and transcranial direct current stimulation assisted rehabilitation in the treatment of cerebrovascular disease-related gait disorders.

mini-mental state examination
hemiplegia
cerebral infarction
transcranial direct current stimulation
dysarthria
  • 0 views
  • 16 Feb, 2024
  • 6 locations
Brief Title: Study of BGB-10188 as Monotherapy and in Combination With Zanubrutinib and Tislelizumab

The purpose of this study is to determine the maximum tolerated dose (MTD), recommended Phase 2 dose(RP2D),safety & tolerability of BGB-10188: as monotherapy in participants with mature B-cell malignancies; oin combination with zanubrutinib in participants with relapse/refractory follicular lymphoma (R/R FL), mantle cell lymphoma (MCL) or diffuse large B-cell lymphoma …

solid tumor
diffuse large b-cell lymphoma
hepatocellular carcinoma
liver cancer
melanoma
  • 0 views
  • 16 Feb, 2024
  • 4 locations